CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Sevilla, Spain and 561 other locations
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Phase 3
Sevilla, Spain and 320 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Sevilla, Andalucía, Spain and 512 other locations
This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...
Phase 2
Sevilla, Spain and 142 other locations
Clinical trials
Research sites
Resources
Legal